变应原免疫治疗中的依从性：现状与未来影响
Adherence in allergen immunotherapy: Current situation and future implications.
作者信息
Gehrt Francesca, Xu Qingqing, Baiardini Ilaria, Canonica Giorgio Walter, Pfaar Oliver
机构信息
Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-University Marburg, Marburg, Germany.
Department of Allergy, Beijing Tong Ren Hospital, Capital Medical University.
出版信息
Allergol Select. 2022 Nov 21;6:276-284. doi: 10.5414/ALX02318E. eCollection 2022.
Abstract
Allergen immunotherapy (AIT) is the only disease-modifying treatment in allergy. However clinical trials as well as real-life studies revealed poor treatment adherence. This article is intended to provide an overview of the current literature of the last 10 years, to outline reasons for poor treatment adherence in AIT and to provide possible solutions for improving adherence.
摘要
变应原免疫疗法（AIT）是唯一一种可改变过敏疾病进程的治疗方法。然而，临床试验以及实际研究均显示治疗依从性较差。本文旨在概述过去10年的现有文献，阐述AIT治疗依从性差的原因，并提供提高依从性的可能解决方案。
相似文献
1
Adherence in allergen immunotherapy: Current situation and future implications.变应原免疫治疗中的依从性：现状与未来影响
Allergol Select. 2022 Nov 21;6:276-284. doi: 10.5414/ALX02318E. eCollection 2022.
3
Transition between subcutaneous and sublingual allergen immunotherapy: Recommendations of the Brazilian Association of Allergy and Immunology (ASBAI).皮下和舌下变应原免疫疗法之间的转换：巴西变态反应与免疫学协会（ASBAI）的建议。
J Allergy Clin Immunol Glob. 2024 May 18;3(3):100281. doi: 10.1016/j.jacig.2024.100281. eCollection 2024 Aug.
4
Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma.变应原免疫治疗：皮下免疫治疗和舌下免疫治疗变应性鼻炎/结膜炎和哮喘的疗效和安全性的证据。
J Allergy Clin Immunol Pract. 2024 Jun;12(6):1415-1427. doi: 10.1016/j.jaip.2024.04.034. Epub 2024 Apr 27.
5
Lack of Harmonized Adherence Criteria in Allergen Immunotherapy Prevents Comparison of Dosing and Application Strategies: A Scoping Review.缺乏变应原免疫治疗的统一依从性标准会阻碍剂量和应用策略的比较：范围综述。
J Allergy Clin Immunol Pract. 2023 Feb;11(2):439-448.e6. doi: 10.1016/j.jaip.2022.10.005. Epub 2022 Oct 20.
6
Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma.草花粉和树花粉诱发的过敏性鼻炎和哮喘患者皮下及舌下免疫疗法的真实世界依从性及证据
Patient Prefer Adherence. 2020 May 13;14:817-827. doi: 10.2147/PPA.S242957. eCollection 2020.
7
Good clinical practice recommendations in allergen immunotherapy: Position paper of the Brazilian Association of Allergy and Immunology - ASBAI.变应原免疫治疗的良好临床实践建议：巴西变态反应与免疫学协会（ASBAI）立场文件
World Allergy Organ J. 2022 Sep 24;15(10):100697. doi: 10.1016/j.waojou.2022.100697. eCollection 2022 Oct.
8
Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report.儿童变应原特异性免疫治疗的临床实践建议：意大利共识报告。
Ital J Pediatr. 2017 Jan 23;43(1):13. doi: 10.1186/s13052-016-0315-y.
9
Essentials of allergen immunotherapy: A primer for the practitioner.变应原免疫治疗基础：从业者指南。
Allergy Asthma Proc. 2022 Jul 1;43(4):245-247. doi: 10.2500/aap.2022.43.220039.
10
A review of clinical efficacy, safety, new developments and adherence to allergen-specific immunotherapy in patients with allergic rhinitis caused by allergy to ragweed pollen ().对豚草花粉过敏所致过敏性鼻炎患者的临床疗效、安全性、新进展及变应原特异性免疫疗法依从性的综述。
Patient Prefer Adherence. 2017 Feb 14;11:247-257. doi: 10.2147/PPA.S70411. eCollection 2017.
引用本文的文献
1
Atopic dermatitis occurrence and progression and allergen immunotherapy: A real-world, retrospective cohort study in Germany.特应性皮炎的发生、进展与变应原免疫疗法：德国一项真实世界回顾性队列研究
World Allergy Organ J. 2025 Aug 5;18(8):101090. doi: 10.1016/j.waojou.2025.101090. eCollection 2025 Aug.
2
Using mobile technology to increase adherence to sublingual immunotherapy: Real-world study with a new app/web platform AllergyVax®.使用移动技术提高舌下免疫疗法的依从性：一项针对新应用程序/网络平台AllergyVax®的真实世界研究。
World Allergy Organ J. 2025 May 12;18(6):101064. doi: 10.1016/j.waojou.2025.101064. eCollection 2025 Jun.
3
α2-3 Sialic Acids-Decorated Allergens Exert a Tolerogenic Effect on CD4+ T Cells from Der p 2-Allergic Patients.α2-3唾液酸修饰的变应原对来自Der p 2过敏患者的CD4+ T细胞具有致耐受性作用。
Int Arch Allergy Immunol. 2025;186(8):703-715. doi: 10.1159/000543157. Epub 2024 Dec 19.
4
V Brazilian Consensus on Rhinitis - 2024.第五届巴西鼻炎共识 - 2024年
Braz J Otorhinolaryngol. 2025 Jan-Feb;91(1):101500. doi: 10.1016/j.bjorl.2024.101500. Epub 2024 Sep 7.
5
An Overview of Adherence-What It Is and Why It Is Important.依从性概述——它是什么以及为何重要。
J Allergy Clin Immunol Pract. 2024 Dec;12(12):3180-3188. doi: 10.1016/j.jaip.2024.07.018. Epub 2024 Jul 27.
6
House dust mite immunotherapy: A real-world, prescription data-based analysis.屋尘螨免疫疗法：一项基于真实世界处方数据的分析。
Clin Transl Allergy. 2024 Jul;14(7):e12382. doi: 10.1002/clt2.12382.
7
Persistence in allergen immunotherapy: A longitudinal, prescription data-based real-world analysis.变应原免疫疗法的持续性：基于纵向处方数据的真实世界分析。
Clin Transl Allergy. 2023 May;13(5):e12245. doi: 10.1002/clt2.12245.
本文引用的文献
2
One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence.变应原免疫治疗的百年历程：从经验观察到循证医学。
Allergy. 2022 Feb;77(2):454-468. doi: 10.1111/all.15023. Epub 2021 Sep 27.
3
Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic.皮下免疫疗法在现实生活中的依从性：COVID-19大流行时代有哪些变化。
World Allergy Organ J. 2021 Jul;14(7):100558. doi: 10.1016/j.waojou.2021.100558. Epub 2021 Jun 8.
4
Peptide allergen-specific immunotherapy for allergic airway diseases-State of the art.用于变应性气道疾病的肽过敏原特异性免疫疗法——最新进展
Clin Exp Allergy. 2021 Jun;51(6):751-769. doi: 10.1111/cea.13840. Epub 2021 Feb 17.
5
Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma.药师实施的教育干预对哮喘患者治疗依从性、疾病控制和肺功能的影响。
Respir Med. 2020 Nov-Dec;174:106199. doi: 10.1016/j.rmed.2020.106199. Epub 2020 Oct 21.
6
Compliance, efficacy, and safety of subcutaneous and sublingual immunotherapy in children with allergic rhinitis.变应性鼻炎患儿皮下和舌下免疫治疗的依从性、疗效和安全性。
Pediatr Allergy Immunol. 2021 Jan;32(1):86-91. doi: 10.1111/pai.13332. Epub 2020 Sep 14.
7
Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma.草花粉和树花粉诱发的过敏性鼻炎和哮喘患者皮下及舌下免疫疗法的真实世界依从性及证据
Patient Prefer Adherence. 2020 May 13;14:817-827. doi: 10.2147/PPA.S242957. eCollection 2020.
8
Perspectives in allergen immunotherapy: 2019 and beyond.变应原免疫治疗的展望：2019 年及以后。
Allergy. 2019 Dec;74 Suppl 108:3-25. doi: 10.1111/all.14077.
9
Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: A retrospective database study in France.草花粉片免疫疗法可减少过敏性鼻炎和哮喘的药物配给：法国回顾性数据库研究。
Allergy. 2019 Jul;74(7):1317-1326. doi: 10.1111/all.13705. Epub 2019 Mar 14.
10
Adherence to Subcutaneous Allergen Immunotherapy in Southeast Turkey: A Real-Life Study.在土耳其东南部地区，皮下变应原免疫治疗的依从性：一项真实世界的研究。
Med Sci Monit. 2018 Dec 11;24:8977-8983. doi: 10.12659/MSM.910860.
Zotero 插件